Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
My View
Tags:
Consumer China Asia Pacific

Industry Roundup: No GRAS For PHOs, Pfizer Expands In China, MusclePharm Targets Over-40 Consumers

This article was originally published in The Tan Sheet

  • News

Executive Summary

Partially hydrogenated oils lose GRAS; Pfizer expands consumer product output in China; MusclePharm adding direct sales; U.K. requires registration, logo for online sales; and more news in brief.

You may also be interested in...



Industry Roundup: Vitamin Shoppe, Walgreen/Rite Aid, BioPharmX

FTC requests more from Walgreen, Rite Aid; SDC manufactures for Axxess; Human Roots expands online sales; and more news in brief.

Industry Roundup: Vitamin Shoppe, Walgreen/Rite Aid, BioPharmX

FTC requests more from Walgreen, Rite Aid; SDC manufactures for Axxess; Human Roots expands online sales; and more news in brief.

Executive Decisions Roundup

POM Wonderful pomegranate dietary supplement marketer The Wonderful Co. is represented in the Aspen Institute’s inaugural “Health Innovators” program; nutritional and sports supplement brands EXOS and MusclePharm and eye care brand EyePromise sign pro athletes; and more news in brief.

Table

View full table

Related Content

Pink Sheet
Pink Sheet

Topics

Related Companies

Tags:
Consumer China Asia Pacific
Latest News

‘A Forever Battle:’ Patent Reform, Launch Prices, And Where Lower Rx Price Advocates Will Go Next

What Might FDA Do Post Roe? Eliminate Mifepristone REMS

Recent And Upcoming FDA Advisory Committee Meetings

US FDA Training Up Inspectorate To Oversee Quality Of Novel Manufacturing Technologies

See All
UsernamePublicRestriction

Register

PS107737

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By